PERITONEAL CARCINOMA

PERITONEAL CARCINOMA was reported 69 times

PERITONEAL CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Mucocutaneous Epithelial Cell Growth Factor [EPC] 1 0.0026
1 Antimalarial [EPC] 1 0.0001
2 Antiprotozoal [EPC] 1 0.0001
3 Topoisomerase Inhibitor [EPC] 6 0.0001
4 Platinum-based Drug [EPC] 13 0.0000
5 Intestinal Lipase Inhibitor [EPC] 1 0.0000
6 Progesterone [EPC] 1 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 13 0.0000
8 Nucleoside Metabolic Inhibitor [EPC] 7 0.0000
9 Polyene Antifungal [EPC] 1 0.0000
10 Alkylating Drug [EPC] 6 0.0000
11 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
12 Vascular Endothelial Growth Factor Inhibitor [EPC] 4 0.0000
13 Purine Antimetabolite [EPC] 2 0.0000
14 Aminosalicylate [EPC] 2 0.0000
15 Antirheumatic Agent [EPC] 2 0.0000
16 Loop Diuretic [EPC] 8 0.0000
17 Estrogen [EPC] 3 0.0000
18 Opioid Agonist [EPC] 4 0.0000
19 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
20 Cardiac Glycoside [EPC] 1 0.0000
21 Vitamin D [EPC] 4 0.0000
22 Vitamin B12 [EPC] 4 0.0000
23 Microtubule Inhibitor [EPC] 2 0.0000
24 Corticosteroid [EPC] 13 0.0000
25 Vitamin C [EPC] 4 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 12 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 9 0.0000
28 Fluoroquinolone Antibacterial [EPC] 1 0.0000
29 alpha-Adrenergic Blocker [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 4 0.0000
31 Osmotic Laxative [EPC] 2 0.0000
32 Calcium [EPC] 1 0.0000
33 beta-Adrenergic Blocker [EPC] 2 0.0000
34 Aldosterone Antagonist [EPC] 1 0.0000
35 Interferon beta [EPC] 1 0.0000
36 Kinase Inhibitor [EPC] 2 0.0000
37 Proton Pump Inhibitor [EPC] 2 0.0000
38 Benzodiazepine [EPC] 2 0.0000
39 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000